MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617059677 A) filed by Medeze Treasury Pte. Ltd on May 11, 2026, for Composition Comprising Avenanthramide C For Inducing Differentiation Of Mesenchymal Stem Cells Into Chondrocytes And Method Of Using The Same.
Inventor includes Khemarangsan, Veerapol.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present invention discloses an application of Avenanthramide C (Avn C) as an inducer of chondrocyte differentiation in Mesenchymal Stem Cells (MSCs), providing a promising approach for regenerative cartilage therapies. By employing Avn C treatments, MSCs exhibit enhanced chondrocyte differentiation...